The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy

Table 3

The baseline and characteristics of patients.

	Control without glucocorticoid	Short term use of glucocorticoid	Long term use of glucocorticoid
Number of patients	22	20	18
Time of glucocorticoid	0	<3 months	>3 months
Glucose fasting (mmol/L)	4.9 ± 1.3	5.1 ± 0.7	5.3 ± 1.1
Glucose 2 h after dinner (mmol/L)	6.9 ± 0.7	7.1 ± 0.7	9.3 ± 2.6
ACTH 8 am (pmol/L)	6.5 ± 0.4	7.2 ± 0.7	7.9 ± 0.3
HDL (high density lipoprotein, mmol/L)	1.49 ± 0.31	1.29 ± 0.24	0.99 ± 0.21
LDL (low density lipoprotein, mmol/L)	2.29 ± 0.81	2.71 ± 0.53	3.09 ± 0.74
TC (total cholesterol, mmol/L)	5.29 ± 0.37	5.61 ± 0.21	5.78 ± 0.52

versus control group.